Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

SHA:600513 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,752	2,829	3,180	2,696	2,782	2,969
Market Cap Growth	93.01%	-11.04%	17.94%	-3.08%	-6.30%	32.30%
Enterprise Value	7,360	3,616	3,816	3,234	3,159	3,137
Last Close Price	20.15	9.81	10.85	9.01	9.15	9.65
PE Ratio	-	33.61	23.55	19.07	23.41	28.83
PS Ratio	2.21	1.31	1.46	1.38	1.69	2.14
PB Ratio	3.31	1.79	2.10	1.91	2.17	2.51
P/TBV Ratio	5.50	2.22	2.58	2.33	2.62	3.03
P/OCF Ratio	-	262.77	19.79	21.13	20.11	32.30
EV/Sales Ratio	2.83	1.67	1.76	1.65	1.92	2.26
EV/EBITDA Ratio	56.98	19.61	16.19	13.27	15.83	17.82
EV/EBIT Ratio	111.61	28.97	21.21	15.94	18.42	20.37
EV/FCF Ratio	-18.27	-	-	-	-	-
Debt / Equity Ratio	0.85	0.56	0.47	0.49	0.44	0.32
Debt / EBITDA Ratio	11.42	4.77	2.99	2.83	2.80	2.17
Asset Turnover	0.73	0.74	0.78	0.77	0.75	0.70
Inventory Turnover	3.25	2.91	3.80	3.79	3.77	2.97
Quick Ratio	0.61	0.67	0.72	0.74	0.85	0.93
Current Ratio	1.14	1.10	1.09	1.10	1.18	1.29
Return on Equity (ROE)	-1.74%	6.88%	10.33%	12.35%	11.36%	10.61%
Return on Assets (ROA)	1.16%	2.66%	4.04%	5.00%	4.87%	4.89%
Return on Invested Capital (ROIC)	-9.50%	4.88%	8.38%	10.88%	10.62%	10.66%
Return on Capital Employed (ROCE)	2.90%	7.40%	11.20%	13.80%	12.80%	12.60%
Earnings Yield	-0.76%	2.97%	4.25%	5.24%	4.27%	3.47%
FCF Yield	-7.00%	-6.15%	-1.26%	-3.45%	-1.21%	-2.77%
Dividend Yield	0.47%	0.91%	1.38%	1.66%	1.37%	1.12%
Payout Ratio	-	60.08%	37.94%	38.48%	33.48%	41.27%
Buyback Yield / Dilution	-0.86%	-1.03%	0.44%	0.46%	-1.31%	-0.48%
Total Shareholder Return	-0.40%	-0.12%	1.82%	2.13%	0.06%	0.64%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.